1 |
Suwiyoga IK (2006). Tes human papillomavirus sebagai skrining alternatif kanker leher rahim. Cermin Dunia Kedokteran, 151, 29-33.
|
2 |
Schmeink C, Massuger L, Lenselink C, et al (2012). Prospective follow-up of 2065 young unscreened women to study human papillomavirus incidence and clearance. Int J Cancer, 133, 172-81.
|
3 |
Shen Y, Gong JM, Li YQ, et al (2013). Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Henan Province, China. Clin Chim Acta, 415, 297-301.
DOI
ScienceOn
|
4 |
Vet JN, de Boer MA, van den Akker BE, et al (2008). Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer, 99, 214-8.
DOI
ScienceOn
|
5 |
von Knebel Doeberitz M (2002). New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer, 38, 2229-42.
DOI
ScienceOn
|
6 |
Wenham RM, Lancaster JM, Berchuck A (2002). Molecular aspects of ovarian cancer. Best Pract Res Clin Obstet Gynaecol, 16, 483-97.
DOI
ScienceOn
|
7 |
Bonanni P, Boccalini S, Bechini A (2009). Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence. Vaccine, 27, 46-53.
|
8 |
Hacker NF (2005). Cervical cancer. In 'Practical gynecologic oncology', eds Berek JS. Lippincott Williams & Wilkins, Philadelphia p 337-95.
|
9 |
de Villiers EM, Fauquet C, Broker TR, et al (2004). Classification of papillomaviruses. Virology, 324, 17-27.
DOI
ScienceOn
|
10 |
Ekalaksananan T, Pientong C, Kongyingyoes B, et al (2011). Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities. Asian Pac J Cancer Prev, 12, 1777-83.
|
11 |
Eleuterio J Jr, Giraldo PC, Goncalves AK, et al (2007). Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Acta Obstet Gynecol Scand, 86, 94-8.
DOI
ScienceOn
|
12 |
Nasioutziki M, Daniilidis A, Dinas K, et al (2011). The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. Int J Gynecol Cancer, 21, 79-85.
DOI
ScienceOn
|
13 |
Kim J, Kim BK, Lee CH, et al (2012). Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. Int J Gynecol Cancer, 22, 1570-6.
|
14 |
Lenselink CH, Melchers WJ, Quint WG, et al (2008). Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One, 3, 3743.
DOI
ScienceOn
|
15 |
Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
DOI
ScienceOn
|
16 |
Roelens J, Reuschenbach M, von Knebel Doeberitz M, et al (2012). p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and metaanalysis. Cancer Cytopathol, 120, 294-307.
DOI
ScienceOn
|
17 |
Rositch AF, Koshiol J, Hudgens MG, et al (2012). Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer, 133, 1271-85.
|
18 |
World Health Organization (2006). Comprehensive cervical cancer control: a guide to essential practice. World Health Organization, Geneva, p 16-7, 92-100.
|